Table 1:

Patient characteristics

CharacteristicValue
Age (mean) (yr)50 ± 12
Sex (No. of patients) (%)
    Male29 (82.8)
    Female6 (17.2)
Primary histopathology (No. of lesions) (%)
    Glioblastoma17 (41.5)
    Anaplastic astrocytoma9 (21.9)
    Anaplastic oligodendroglioma4 (9.8)
    Oligodendroglioma7 (17.1)
    Others4 (9.7)
WHO classification (No. of lesions) (%)
    Grade II9 (22.0)
    Grade III13 (31.7)
    Grade IV19 (46.3)
Primary site of glioma (No. of lesions) (%)
    Frontal15 (36.6)
    Parietal2 (4.9)
    Temporal10 (24.4)
    Multilobar14 (34.1)
Primary treatment (No. of patients) (%)
    Operation+radiation therapy6 (17.2)
    Operation+radiation therapy+chemotherapy29 (82.8)
Final diagnosis (No. of lesions) (%)
    Recurrence30 (73.2)
        Histopathology21 (51.2)
        Clinicoradiologic follow-up9 (22.0)
    Treatment-induced necrosis11 (26.8)
        Histopathology2 (4.9)
        Clinicoradiologic follow-up9 (21.9)

  • Note:—WHO indicates World Health Organization.